Skip to content
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Gynecology

When Is Colposcopy or Biopsy Needed for Chronic Cervicitis?

At a Glance

Chronic cervicitis alone does not automatically require colposcopy or cervical biopsy. These tests may be recommended for concerning Pap or HPV results, a visibly abnormal cervix, or persistent bleeding after sex, with pregnancy affecting which procedures are safe.

Having chronic cervicitis simply means your cervix has long-term inflammation, usually caused by an infection or irritation. A diagnosis of chronic cervicitis alone does not mean you automatically need a colposcopy or a cervical biopsy. Instead, your doctor will recommend these procedures if there are specific warning signs that require them to rule out cervical precancer (dysplasia) or cervical cancer.

The primary triggers for needing a colposcopy or biopsy usually include abnormal cervical screening results, a visibly suspicious cervix during a physical exam, or persistent symptoms like bleeding after sex that require thorough diagnostic evaluation.

Abnormal Pap Smear or High-Risk HPV Results

Having chronic cervicitis does not change standard cervical cancer screening guidelines. If your routine screening raises a concern, your doctor will use a risk-based framework to decide if a colposcopy is needed, taking into account your specific test results, age, and previous screening history [1].

You will typically be referred for a colposcopy if:

  • You test positive for higher-risk HPV types, specifically HPV 16 or HPV 18 [2].
  • Your Pap smear shows high-grade cellular changes (HSIL), regardless of your HPV status [3].
  • You have persistent low-grade abnormalities or an ongoing high-risk HPV infection that hasn’t cleared up over time [4][5].

(Note: Being referred for a colposcopy does not mean you have cancer. In fact, if you test positive for a high-risk HPV strain other than 16 or 18 and your cell cytology is normal, your doctor may simply recommend repeating the test in one year rather than performing an immediate colposcopy [6].)

A Suspicious or Irregular-Appearing Cervix

During a standard pelvic exam, your doctor looks at the surface of your cervix. Sometimes, inflammation can make the tissue look bulky, firm, or friable (meaning it bleeds very easily when barely touched) [7]. While these changes can be entirely benign and related to your cervicitis, a visibly suspicious area may require a tissue diagnosis [8].

A biopsy may be considered if your doctor sees a distinct growth, mass, or ulceration [8]. Even if your recent Pap smear was completely normal, screening tests can sometimes miss underlying issues, and evaluating a visibly abnormal cervix with a biopsy ensures that precancer or invasive cancer is not overlooked [9][10].

Persistent Symptoms and Postcoital Bleeding

If you have been treated for a cervical infection or inflammation but continue to have heavy discharge, pelvic pain, or bleeding, the next step is usually clinical reassessment rather than an automatic biopsy. Your doctor will likely re-evaluate you for other infections, cervical polyps, or other benign causes [11][12].

However, persistent bleeding after sex (postcoital bleeding) warrants a careful evaluation. While it can be caused by benign issues like cervical polyps, ectropion, or the cervicitis itself [13], unexplained and persistent bleeding after sex is a known warning sign. It requires a thorough diagnostic assessment (which may include a colposcopy) to ensure it is not being caused by cervical dysplasia or malignancy [14][15].

Safety Note: Seek prompt medical care if you experience very heavy bleeding, severe pelvic pain, dizziness, fainting, foul-smelling discharge, or fever, or if you have any of these symptoms and might be pregnant.

What Do These Procedures Involve?

If your doctor recommends further testing, it means they want a closer look to understand what is happening on a microscopic level.

  • Colposcopy: The doctor uses a lighted magnifying instrument (a colposcope) to closely examine the surface tissue and blood vessel patterns of the cervix [16]. It may cause mild discomfort from the speculum or the vinegar-like solution used to highlight abnormal areas. If no concerning lesions are seen, a biopsy might not be needed.
  • Directed Biopsy: If an abnormal area is spotted during the colposcopy, the doctor takes a tiny tissue sample. A pathologist examines this tissue to distinguish benign chronic inflammation from Cervical Intraepithelial Neoplasia (CIN) (precancerous changes) or invasive cancer [17]. You may feel a quick pinch or cramping during the biopsy, and experience mild spotting for a few days afterward.
  • Endocervical Curettage (ECC): This procedure uses a small tool to gently sample the endocervix (the inner cervical canal) where standard surface biopsies cannot reach [18]. It is typically used if you have high-grade cytology, HPV 16/18, or if the doctor cannot fully see the transformation zone (the area where most cervical abnormalities start) [19]. ECC is generally contraindicated during pregnancy, so you must tell your clinician if you are or might be pregnant before the procedure [19].

What If the Biopsy Only Shows Cervicitis?

If a biopsy comes back showing only “chronic cervicitis” and no precancerous cells, this is generally reassuring. However, this reassurance depends on whether the tissue sample was adequate and whether it fully explains the concerning areas the doctor saw during the exam [20]. Your exact follow-up plan and timeline for additional testing will depend on your specific pathology report, your initial screening risk, and whether your symptoms continue.

Common questions in this guide

Does chronic cervicitis automatically mean I need a colposcopy or biopsy?
No. Chronic cervicitis alone does not automatically require either procedure. Your clinician may recommend further evaluation if your Pap or HPV results are concerning, the cervix looks abnormal, or symptoms such as persistent bleeding after sex need explanation.
Which Pap or HPV results can lead to a colposcopy?
Colposcopy is commonly considered after HPV 16 or 18 is detected, high-grade cell changes are found on a Pap test, or low-grade abnormalities or high-risk HPV persist. If another high-risk HPV type is present but the Pap test is normal, repeating testing in about a year may be appropriate instead, depending on your risk history.
Can I need a biopsy even if my Pap test was normal?
Yes. A visible growth, mass, ulcer, or other suspicious area on the cervix may need a tissue sample because screening tests can miss some problems. The biopsy helps distinguish inflammation from precancerous changes or cancer.
What happens during a colposcopy or cervical biopsy?
During colposcopy, a clinician uses magnification and a solution to examine the cervix more closely. If an abnormal area is seen, a small biopsy may be taken, which can cause a brief pinch or cramping and light spotting afterward. A sample from the inner cervical canal may also be collected when needed.
Is endocervical curettage safe during pregnancy?
Endocervical curettage, which samples the inner cervical canal, is generally not performed during pregnancy. Tell your clinician if you are pregnant or might be pregnant before colposcopy-related sampling so the evaluation can be planned safely.
What does it mean if my biopsy shows only chronic cervicitis?
A biopsy showing only chronic cervicitis and no precancerous cells is generally reassuring. Your follow-up still depends on whether the sample was adequate, whether it included the area of concern, your Pap and HPV risk, and whether symptoms continue.
When should I seek urgent care for cervicitis symptoms?
Seek prompt medical care for very heavy bleeding, severe pelvic pain, dizziness, fainting, foul-smelling discharge, or fever. If these symptoms occur while you are pregnant or might be pregnant, contact a clinician urgently.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on chronic cervicitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my exact Pap and HPV results, what is my estimated risk score, and is that why a colposcopy is being recommended?
  2. 2.Are you recommending a colposcopy or biopsy because of my screening results, my symptoms, or how my cervix looks on examination?
  3. 3.Was the entire transformation zone visible during the exam, and did the biopsy adequately sample the concerning areas?
  4. 4.If the biopsy shows only chronic cervicitis, what will be our specific plan and follow-up timeline if my symptoms continue?
  5. 5.Am I pregnant or immunosuppressed in a way that changes the safety or strategy of our management plan?

References

References (20)
  1. 1

    Diagnosis and Management of Cervical Squamous Intraepithelial Lesions in Pregnancy and Postpartum.

    Larish A, Long ME

    Obstetrics and gynecology 2024; (144(3)):328-338 doi:10.1097/AOG.0000000000005566.

    PMID: 38547493
  2. 2

    Applying Results of Extended Genotyping to Management of Positive Cervicovaginal Human Papillomavirus Test Results: Enduring Guidelines.

    Massad LS, Clarke MA, Perkins RB, et al.

    Journal of lower genital tract disease 2025; (29(2)):134-143 doi:10.1097/LGT.0000000000000865.

    PMID: 39791481
  3. 3

    Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.

    Demarco M, Lorey TS, Fetterman B, et al.

    Journal of lower genital tract disease 2017; (21(4)):261-267 doi:10.1097/LGT.0000000000000343.

    PMID: 28953116
  4. 4

    Benefits and potential harms of human papillomavirus (HPV)-based cervical cancer screening: A real-world comparison of HPV testing versus cytology.

    Thomsen LT, Kjaer SK, Munk C, et al.

    Acta obstetricia et gynecologica Scandinavica 2021; (100(3)):394-402 doi:10.1111/aogs.14121.

    PMID: 33566361
  5. 5

    Clinical efficacy of primary human papillomavirus (HPV) screening with partial genotyping for HPV-16 and HPV-18 subtypes in women from 25 years old.

    Ang JX, Lee WY, Tay SK

    Annals of the Academy of Medicine, Singapore 2023; (52(5)):259-267 doi:10.47102/annals-acadmedsg.2022471.

    PMID: 38904523
  6. 6

    Self-Collected Vaginal Specimens for HPV Testing: Recommendations From the Enduring Consensus Cervical Cancer Screening and Management Guidelines Committee.

    Wentzensen N, Massad LS, Clarke MA, et al.

    Journal of lower genital tract disease 2025; (29(2)):144-152 doi:10.1097/LGT.0000000000000885.

    PMID: 39982254
  7. 7

    Analysis of Sensitivity, Specificity, and Positive and Negative Predictive Values of Smear and Colposcopy in Diagnosis of Premalignant and Malignant Cervical Lesions.

    Barut MU, Kale A, Kuyumcuoğlu U, et al.

    Medical science monitor : international medical journal of experimental and clinical research 2015; (21()):3860-7 doi:10.12659/msm.895227.

    PMID: 26655816
  8. 8

    Tuberculosis of Cervix Resembling Cervical Cancer.

    Rodpenpear N

    Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2016; (99 Suppl 8()):S249-S252.

    PMID: 29906057
  9. 9

    Case Report: Diagnosis of cervical carcinoma from pelvic tumor during pregnancy.

    Hase EA, Cruz MCM, Kondo MM, et al.

    Frontiers in medicine 2025; (12()):1648261 doi:10.3389/fmed.2025.1648261.

    PMID: 40873803
  10. 10

    Reason for improper simple hysterectomy in invasive cervical cancer in Northeast India.

    Liegise H, Barmon D, Baruah U, et al.

    Journal of cancer research and therapeutics 2022; (18(6)):1564-1568 doi:10.4103/jcrt.JCRT_1005_20.

    PMID: 36412411
  11. 11

    Atypical presentation of herpes simplex virus 2 primary infection: a case report.

    Herbin C, Jadoul P, Hosten E, et al.

    Journal of medical case reports 2024; (18(1)):393 doi:10.1186/s13256-024-04721-x.

    PMID: 39182131
  12. 12

    2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge.

    Sherrard J, Wilson J, Donders G, et al.

    International journal of STD & AIDS 2018; (29(13)):1258-1272 doi:10.1177/0956462418785451.

    PMID: 30049258
  13. 13

    Comorbidity profiles among women with postcoital bleeding: a nationwide health insurance database.

    Liu HL, Chen CM, Pai LW, et al.

    Archives of gynecology and obstetrics 2017; (295(4)):935-941 doi:10.1007/s00404-017-4327-7.

    PMID: 28246983
  14. 14

    Cytology and high-risk human papillomavirus testing to reduce colposcopies in women with postcoital bleeding.

    Goudira NC, Sherzai F, Petersen LK

    Danish medical journal 2025; (72(12)) doi:10.61409/A12240920.

    PMID: 41312706
  15. 15

    The incidence of cervical cancer in women with postcoital bleeding and abnormal appearance of the cervix referred through the 2-week wait pathway in the United Kingdom: A retrospective cohort study.

    Jasper B, Thorley E, Martins FC, Haldar K

    The journal of obstetrics and gynaecology research 2022; (48(11)):2872-2878 doi:10.1111/jog.15366.

    PMID: 35908174
  16. 16

    Colposcopic evaluation of unhealthy cervix in gynecology patients: A prospective observational study.

    Kori A, Ahirwar M, Meravi J, et al.

    Bioinformation 2025; (21(7)):2001-2005 doi:10.6026/973206300212001.

    PMID: 41170108
  17. 17

    Accuracy of colposcopy-directed biopsy in detecting early cervical neoplasia: a retrospective study.

    Stuebs FA, Schulmeyer CE, Mehlhorn G, et al.

    Archives of gynecology and obstetrics 2019; (299(2)):525-532 doi:10.1007/s00404-018-4953-8.

    PMID: 30367250
  18. 18

    Additional Diagnostic Yield of Endocervical Curettage in Type 3 Transformation Zone for High-Grade Cervical Lesions: A Retrospective Analysis by Human Papillomavirus Genotype.

    Rusu EL, Buciu VB, Balan L, et al.

    Diagnostics (Basel, Switzerland) 2026; (16(8)) doi:10.3390/diagnostics16081220.

    PMID: 42072845
  19. 19

    Colposcopy Standards: Guidelines for Endocervical Curettage at Colposcopy.

    Massad LS, Perkins RB, Naresh A, et al.

    Journal of lower genital tract disease 2023; (27(1)):97-101 doi:10.1097/LGT.0000000000000710.

    PMID: 36222824
  20. 20

    The Help of HPV Integration Testing to Avoid the Misdiagnosis of a Patient with Stage Ia1 Cervical Cancer: A Case Report and Literature Review.

    Li J, Zhang X, Wang P, Li W

    Pharmacogenomics and personalized medicine 2021; (14()):1457-1461 doi:10.2147/PGPM.S310345.

    PMID: 34819743

This page is for informational purposes only and does not constitute medical advice. A gynecologist or other clinician should interpret your Pap and HPV results, symptoms, pregnancy status, and examination findings.